Dr Jan Schmidt-Brand
Spokesman of the Executive Management Board and Chief Financial Officer
Dr Jan Schmidt-Brand has been Chief Financial Officer and member of the Executive Board of WILEX AG since September 1, 2012 and also serves as CEO of the subsidiary Heidelberg Pharma GmbH. Until the acquisition by WILEX AG Dr Schmidt-Brand held the position of CEO/CFO in the former Heidelberg Pharma AG. The doctor of law has over 20 years’ experience in leading positions in the commercial as well as the fiscal sector of pharmaceutical companies. From 1997 to 2001 he was Managing Director of EBEWE Arzneimittel GmbH, an Austrian BASF Pharma subsidiary. Prior to this, he held several positions at the BASF Group for a total of eight years, most recently as an executive in the central tax department with a general commercial power of attorney (“Prokurist”). Dr Jan Schmidt-Brand studied law, business management and French at the universities of Bayreuth and Geneva and obtained his doctoral degree from the University of Mannheim. He has been member of the board of directors of BIO Deutschland e.V. and head of the Finance and Tax working group since 2007. Furthermore, Dr Schmidt-Brand is a deputy Supervisory Board member of BIOPRO Baden-Württemberg GmbH and spokesman of the Industrial Advisory Board of the Faculty of Biotechnology at the Mannheim University of Applied Sciences.
Prof. Dr. Andreas Pahl
Head of Research and Development
Professor Andreas Pahl has been appointed to serve as Head of Research and Development of WILEX AG on June 2, 2016. Professor Pahl has worked successfully as Chief Scientific Officer and member of the executive management of WILEX’s subsidiary Heidelberg Pharma GmbH since September 2012, and can look back on 20 years’ experience in research and higher education. Prior to his position at Heidelberg Pharma, he spent four years as Head of Late Pharmacology at Nycomed and Takeda Pharmaceuticals. After graduating in chemistry from the University of Berlin, he spent several years lecturing at TU Berlin and the University of Erlangen-Nuremberg (FAU), at which he was also appointed Professor of Pharmacology and Toxicology. Professor Pahl will continue to perform his teaching duties at FAU.